Equity Analysis

Quarterly Results

    Lincoln Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    531633
    INE405C01035
    295.9780223
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    LINCOLN
    14.02
    1373.04
    EPS(TTM)
    Face Value()
    Div & Yield %:
    48.91
    10
    0.26
     
Quarters
(RupeeIcon Cr)
ParticularsJun 2024Mar 2024Dec 2023
Gross Sales147.28142.49146.45
Other Operating Income0.000.000.00
Other Income 10.417.0211.02
Total Income157.69149.51157.47
Total Expenditure 124.55124.11116.79
PBIDT33.1425.4040.68
Interest 0.440.500.15
PBDT32.7024.9040.52
Depreciation3.222.692.81
Tax5.514.117.21
Fringe Benefit Tax0.000.000.00
Deferred Tax0.29-0.492.46
Reported Profit After Tax23.6718.6028.04
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item23.6718.6028.04
EPS (Unit Curr.)11.829.2814.00
EPS (Adj) (Unit Curr.)11.829.2814.00
Calculated EPS (Unit Curr.)11.829.2814.00
Calculated EPS (Adj) (Unit Curr.)11.829.2814.00
Calculated EPS (Ann.) (Unit Curr.)47.2737.1456.00
Calculated EPS (Adj) (Ann.) (Unit Curr.)47.2737.1456.00
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity20.0320.0320.03
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)22.5017.8327.78
PBDTM(%)22.2017.4727.67
PATM(%)16.0713.0519.15
Dividend Per Share(Rs)0.000.000.00
Diluted EPS11.829.2814.00